We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.82B
1-Year Est. Return
43.51%
This Fund
S&P 500
This Quarter
Est. Return
+15.83%
1 Year Est. Return
+43.51%
3 Year Est. Return
+157.95%
5 Year Est. Return
+295.76%
10 Year Est. Return
+2,156.01%
AUM
$7.92B
AUM Growth
+$2.08B
(+36%)
Cap. Flow
+$1.28B
Cap. Flow
% of AUM
16.13%
Top 10 Holdings %
Top 10 Hldgs %
41.43%
Holding
197
New
67
Increased
35
Reduced
38
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$372M |
| 2 |
Dollar General
DG
|
+$308M |
| 3 |
HCA Healthcare
HCA
|
+$305M |
| 4 |
Charter Communications
CHTR
|
+$180M |
| 5 |
CF Industries
CF
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$210M |
| 2 |
LyondellBasell Industries
LYB
|
+$202M |
| 3 |
Boeing
BA
|
+$181M |
| 4 |
FedEx
FDX
|
+$151M |
| 5 |
American International
AIG
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 21.57% |
| 2 | Healthcare | 21.36% |
| 3 | Energy | 20.45% |
| 4 | Industrials | 10.54% |
| 5 | Miscellaneous | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Madison Square Garden
MSGS
$9.47B
| $7.43M | 0.09% |
+180,998
| New | +$7.37M |
|
102
Plains GP Holdings
PAGP
$5.54B
| $7.11M | 0.09% |
+99,662
| New | +$6.24M |
|
|
EOX
103
DELISTED
EMERALD OIL INC (MT)
EOX
| $6.95M | 0.09% |
45,375
-26,475
| -37% | -$4.09M |
|
|
ZQK
104
DELISTED
QUICKSILVER,INC.
ZQK
| $6.44M | 0.08% |
+734,600
| New | +$5.95M |
|
|
RCPT
105
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $6.38M | 0.08% |
+220,000
| New | +$5.89M |
|
|
QVCGA
106
DELISTED
QVC Group Inc Series A
QVCGA
| $6.3M | 0.08% |
5,225
-17,361
| -77% | -$19.3M |
|
107
Lamar Advertising Co
LAMR
$15.2B
| $6.25M | 0.08% |
+119,700
| New | +$5.85M |
|
|
MNTA
108
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $6.19M | 0.08% |
+350,000
| New | +$5.88M |
|
|
NLSN
109
DELISTED
Nielsen Holdings plc
NLSN
| $5.43M | 0.07% |
+118,300
| New | +$4.83M |
|
110
AutoZone
AZO
$47.7B
| $5.26M | 0.07% |
11,000
+1,400
| +15% | +$628K |
|
111
Travel + Leisure Co
TNL
$4.01B
| $5.25M | 0.07% |
157,930
-116,509
| -42% | -$3.57M |
|
112
Dollar Tree
DLTR
$21.5B
| $5.03M | 0.06% |
+89,200
| New | +$5.14M |
|
|
OPLN
113
Openlane
OPLN
$4.28B
| $4.95M | 0.06% |
442,799
+66,050
| +18% | +$717K |
|
|
RPRX
114
DELISTED
Repros Therapeutics Inc.
RPRX
| $4.94M | 0.06% |
+270,000
| New | +$5.1M |
|
115
MacroGenics
MGNX
$255M
| $4.94M | 0.06% |
+180,000
| New | +$4.71M |
|
116
Puma Biotechnology
PBYI
$475M
| $4.66M | 0.06% |
+45,000
| New | +$2.64M |
|
117
Nexstar Media Group
NXST
$5.16B
| $4.65M | 0.06% |
+83,500
| New | +$3.99M |
|
|
CLVS
118
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.52M | 0.06% |
75,000
+10,000
| +15% | +$544K |
|
|
ECHO
119
EchoStar
ECHO
$27B
| $4.49M | 0.06% |
111,430
+26,161
| +31% | +$1.02M |
|
|
S
120
DELISTED
Sprint Corporation
S
| $4.32M | 0.05% |
+401,800
| New | +$3.03M |
|
|
WNR
121
DELISTED
Western Refining Inc
WNR
| $4.28M | 0.05% |
+101,000
| New | +$3.63M |
|
|
GNMK
122
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.97M | 0.05% |
298,976
| – | – |
|
123
Insmed
INSM
$26.1B
| $3.4M | 0.04% |
+200,000
| New | +$3.06M |
|
124
Bank of America
BAC
$418B
| $3.36M | 0.04% |
+215,900
| New | +$3.2M |
|
|
GDP
125
PUT
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
| $3.23M | 0.04% |
+190,000
| New | +$4.08M |
|
Similar funds
MNA
BFG
PFA
FFM
EMPI
LAM
UB
IMCOOI
PointState Capital's Q4 2013 Portfolio in Review
As of Q4 2013, PointState Capital held 197 positions worth $7.92B, up 36% from $5.84B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
PointState Capital deployed $1.28B of net new capital in Q4 2013, opening 67 new positions and adding to 35 existing holdings. Its largest new stake was Teva Pharmaceuticals: 9,445,400 shares worth $379M.
By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $210M trimmed.
- PointState Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 9,445,400 shares worth $379M.
- PointState Capital added most to Dollar General in Q4 2013, an estimated $308M increase.
- PointState Capital's biggest Q4 2013 reduction was Allergan Inc, cutting an estimated $210M.
- PointState Capital fully exited LyondellBasell Industries in Q4 2013, selling an estimated $202M.
- PointState Capital's ten largest holdings make up 41% of its $7.92B portfolio in Q4 2013.
- PointState Capital opened 67 new positions and closed 55 in Q4 2013.
- PointState Capital's portfolio value rose 36% quarter-over-quarter to $7.92B.
Based on PointState Capital's 13F filing for Q4 2013, filed 14 Feb 2014.